This research investigates how declining ovarian health influences brain aging and dementia risk. Using genetically engineered mouse models, it identifies inflammation and metabolic stress in the hippocampus associated with low egg quality, suggesting that treatments targeting menopause, hormonal imbalance, or insulin resistance could help protect cognitive health and prevent dementia.

This research develops orally administered nanoparticles that target the lymphatic system to treat lupus and osteoporosis simultaneously. By delivering drugs directly to affected tissues while avoiding the bloodstream, the approach reduces toxicity, suppresses inflammatory and bone-damaging genes, and offers a more effective strategy for treating these complex chronic diseases.